Similar articles for PMID: 22230748

Year	Number of Results
1994	1
1995	1
1996	1
1997	3
1998	1
1999	6
2000	1
2001	4
2002	5
2003	2
2004	5
2005	10
2006	13
2007	9
2008	8
2009	12
2010	12
2011	18
2012	27
2013	28
2014	21
2015	24
2016	35
2017	37
2018	22
2019	24
2020	30
2021	44
2022	15
2023	7
2024	0

1

Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.

Song S, Wang Y, Wang J, Lian W, Liu S, Zhang Z, Liu F, Wei L. Song S, et al. Eur J Cancer. 2012 Sep;48(14):2252-9. doi: 10.1016/j.ejca.2011.12.009. Epub 2012 Jan 7. Eur J Cancer. 2012. PMID: 22230748

2

[Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].

Wang Z, You H, Song S. Wang Z, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Apr;29(4):379-83. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013. PMID: 23643168 Chinese.

3

Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.

Heo MB, Cho MY, Lim YT. Heo MB, et al. Acta Biomater. 2014 May;10(5):2169-76. doi: 10.1016/j.actbio.2013.12.050. Epub 2014 Jan 4. Acta Biomater. 2014. PMID: 24394635

4

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H. Ojima T, et al. Int J Oncol. 2006 Apr;28(4):947-53. Int J Oncol. 2006. PMID: 16525645

5

Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.

Wang J, Saffold S, Cao X, Krauss J, Chen W. Wang J, et al. J Immunol. 1998 Nov 15;161(10):5516-24. J Immunol. 1998. PMID: 9820528

6

The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.

Lai C, Duan S, Ye F, Hou X, Li X, Zhao J, Yu X, Hu Z, Tang Z, Mo F, Yang X, Lu X. Lai C, et al. Theranostics. 2018 Feb 12;8(6):1723-1739. doi: 10.7150/thno.22056. eCollection 2018. Theranostics. 2018. PMID: 29556352 Free PMC article.

7

[Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].

Song HF, Zhou J, Pan K, Wang QJ, Wang H, Huang LX, Li YQ, Xia JC. Song HF, et al. Ai Zheng. 2008 Jul;27(7):685-91. Ai Zheng. 2008. PMID: 18606059 Free article. Chinese.

8

[Silencing of SOCS1 and IL-12 gene cotransferred by adenoviral enhances DC-mediated anti-laryngocarcinoma immunity in vitro].

Li Y, Yuan Y, Wang X. Li Y, et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Oct;26(19):890-2, 896. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012. PMID: 23285955 Chinese.

9

Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.

Shi D, Li D, Yin Q, Qiu Y, Yan H, Shen Y, Lu G, Liu W. Shi D, et al. Immunol Res. 2015 Mar;61(3):206-18. doi: 10.1007/s12026-014-8562-8. Immunol Res. 2015. PMID: 25381480 Free PMC article.

10

Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.

Zhou H, Zhang D, Wang Y, Dai M, Zhang L, Liu W, Liu D, Tan H, Huang Z. Zhou H, et al. Biochem Biophys Res Commun. 2006 Aug 18;347(1):200-7. doi: 10.1016/j.bbrc.2006.06.093. Epub 2006 Jun 23. Biochem Biophys Res Commun. 2006. PMID: 16815301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

385 results

Results by year